Auransa to Receive Upfront Payment and be Eligible for Milestone Payments and Sales Royalties for Preclinical Program Identified by Company's AI-Driven ...
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2R5WLtC
Τετάρτη 19 Δεκεμβρίου 2018
Auransa Enters into Exclusive Licensing Agreement with China Oncology Focus Limited, an Affiliate of Lee's Pharmaceutical Holdings, for Rights to AU018 in Greater China and Southeast Asia - GlobeNewswire
Auransa Enters into Exclusive Licensing Agreement with China Oncology Focus Limited, an Affiliate of Lee's Pharmaceutical Holdings, for Rights to AU018 in Greater China and Southeast Asia GlobeNewswire
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2R5WLtC
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2R5WLtC
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.